Clinical Trials
195 trialsBACCHUS
University Hospital, Lille
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
CRC-ORGA2
University Hospital, Grenoble
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
Peking University
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
CrEATE
UMC Utrecht
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
University of Michigan Rogel Cancer Center
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
University of California, Irvine
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Alliance for Clinical Trials in Oncology
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
U-TRANS
Gustave Roussy, Cancer Campus, Grand Paris
FORTE
NRG Oncology
CIRCULATE-US
NRG Oncology
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
iCaRe2
University of Nebraska
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Clinicopathological Characteristics of Colon Cancer in Young Age
Seoul National University Bundang Hospital
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
Shandong Cancer Hospital and Institute
DEMETRA
San Raffaele University
ACBC
Skane University Hospital
UMC-Colprep
University Medical Center Ho Chi Minh City (UMC)
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University
NEOPRISM-CRC
University College, London
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
PSI-Immune
University of Pittsburgh
NIMA
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Case Comprehensive Cancer Center
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
Ohio State University Comprehensive Cancer Center
SURGE
Colorado State University
ASAP
Avera McKennan Hospital & University Health Center
MIMICC
Fondazione del Piemonte per l'Oncologia
(CLOCS-2)
Imperial College London
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Chungnam National University Hospital
REACH
Dana-Farber Cancer Institute
SCOTI
Rutgers, The State University of New Jersey
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Copenhagen University Hospital at Herlev
FRUITFUL
SCRI Development Innovations, LLC
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Memorial Sloan Kettering Cancer Center
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
PILDI
Institute of Oncology Ljubljana
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
NICHE
The Netherlands Cancer Institute
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
BEACON
San Raffaele University
miR-CIPN#1
University Hospital, Clermont-Ferrand